These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2340517)

  • 41. Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell lines.
    Van Moorsel CJ; Smid K; Voorn DA; Bergman AM; Pinedo HM; Peters GJ
    Int J Oncol; 2003 Jan; 22(1):201-7. PubMed ID: 12469205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
    Amsailale R; Van Den Neste E; Arts A; Starczewska E; Bontemps F; Smal C
    Biochem Pharmacol; 2012 Jul; 84(1):43-51. PubMed ID: 22490700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
    White JC; Capizzi RL
    Cancer Res; 1991 May; 51(10):2559-65. PubMed ID: 2021937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.
    Grunewald R; Kantarjian H; Keating MJ; Abbruzzese J; Tarassoff P; Plunkett W
    Cancer Res; 1990 Nov; 50(21):6823-6. PubMed ID: 2208147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
    Bouffard DY; Momparler LF; Momparler RL
    Anticancer Drugs; 1991 Feb; 2(1):49-55. PubMed ID: 1958852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA).
    Cohen SS
    Cancer; 1977 Jul; 40(1 Suppl):509-18. PubMed ID: 328134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine.
    Grunewald R; Abbruzzese JL; Tarassoff P; Plunkett W
    Cancer Chemother Pharmacol; 1991; 27(4):258-62. PubMed ID: 1998982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
    Verhoef V; Fridland A
    Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.
    Santini V; Bernabei A; Gozzini A; Scappini B; Zoccolante A; D'Ippolito G; Figuccia M; Ferrini PR
    Haematologica; 1997; 82(1):11-5. PubMed ID: 9172997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography.
    Nishi R; Yamauchi T; Ueda T
    Cancer Sci; 2006 Nov; 97(11):1274-8. PubMed ID: 17034368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1.
    Prakasha Gowda AS; Polizzi JM; Eckert KA; Spratt TE
    Biochemistry; 2010 Jun; 49(23):4833-40. PubMed ID: 20459144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preclinical characteristics of gemcitabine.
    Plunkett W; Huang P; Gandhi V
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():7-13. PubMed ID: 8718419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and beta-D-arabinofuranosylcytosine).
    Lam W; Park SY; Leung CH; Cheng YC
    Mol Pharmacol; 2006 May; 69(5):1607-14. PubMed ID: 16481390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aphidicolin potentiates apoptosis induced by arabinosyl nucleosides in human myeloid leukemia cell lines.
    Kuwakado K; Kubota M; Hirota H; Adachi S; Matsubara K; Kasai Y; Akiyama Y; Mikawa H
    Biochem Pharmacol; 1993 Dec; 46(11):1909-16. PubMed ID: 8267640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic.
    Bookman MA
    Int J Gynecol Cancer; 2005; 15 Suppl 1():12-7. PubMed ID: 15839953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair.
    Yang LY; Li L; Jiang H; Shen Y; Plunkett W
    Clin Cancer Res; 2000 Mar; 6(3):773-81. PubMed ID: 10741696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nucleotide specificity of human deoxycytidine kinase.
    Shewach DS; Reynolds KK; Hertel L
    Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Bhalla K; McCrady C
    Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine.
    Veltkamp SA; Pluim D; van Eijndhoven MA; Bolijn MJ; Ong FH; Govindarajan R; Unadkat JD; Beijnen JH; Schellens JH
    Mol Cancer Ther; 2008 Aug; 7(8):2415-25. PubMed ID: 18723487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism.
    Heinemann V; Schulz L; Issels RD; Plunkett W
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):11-8. PubMed ID: 7481839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.